Effects of Kratom (Mitragyna Speciosa Korth.) Use in Regular Users

References

• Adkins, J. E., Boyer, E. W., & McCurdy, C. R. (2011). Mitragyna speciosa, A psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry, 11, 1165–1175.
   PubMed Web of Science ®Google Scholar
• Ahmad, K., & Aziz, Z. (2012). Mitragyna speciosa use in the northern states of Malaysia: Cross-sectional study. Journal of Ethnopharmacology, 141(1), 446–450.
   PubMed Web of Science ®Google Scholar
• Assanangkornchai, S., Muekthong, A., Sam-Angsri, N., & Pattanasattayawong, U. (2007). The use of Mitragyna speciosa (‘kratom’), an addictive plant, in Thailand. Substance Use & Misuse, 42(14), 2145–2157. doi: 10.1080/10826080701205869
   PubMed Web of Science ®Google Scholar
• Brown, P. N., Lund, J. A., & Murch, S. J. (2017). A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna Korth: Implications for products sold as kratom. Journal of Ethnopharmacology, 202, 302–325. doi: 10.1016/j.jep.2017.03.020
   PubMed Web of Science ®Google Scholar
• EMCDD, Kratom drug profile. http://www.emcdda.europa.eu/publications/drug-profiles/kratom.
   Google Scholar
• Grewal, K. S. (1932). The effect of mitragynine on man. British Journal of Medical Psychology, 12(1), 41–58. doi: 10.1111/j.2044-8341.1932.tb01062.x
   Google Scholar
• Grundmann, O. (2017). Patterns of Kratom use and health impact in the US-Results from an online survey. Drug and Alcohol Dependence, 176, 63–70. doi: 10.1016/j.drugalcdep.2017.03.007
   PubMed Web of Science ®Google Scholar
• Hanajiri, R. K., Kawamura, T. M., Kitajima, M., Takayama, H., & Goda, Y. (2009). Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant “kratom” (Miyragyna speciosa) by LC-ESI-MS. Forensic Toxicology, 27, 67–74. doi: 10.1007/s11419-009-0070-5
   Web of Science ®Google Scholar
• Henningfield, J.E., Fant, R.V., & Wang, D.W. (2017). The abuse potential of kratom according the 8 factor of the controlled substances act: implications for regulation and research. Psychopharmacology, 235, 573–589.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., & Grundmann, O. (2018). The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology, 134, 108–120. doi: 10.1016/j.neuropharm.2017.08.026
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., Gassaway, M. M., Kapoor, A., Váradi, A., Majumdar, S., Filizola, M., … Sames, D. (2016). Synthetic and receptor signaling explorations of the mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators. Journal of the American Chemical Society, 138(21), 6754–6756. doi: 10.1021/jacs.6b00360
   PubMed Web of Science ®Google Scholar
• Lydecker, A. G., Sharma, A., McCurdy, C. R., Avery, B. A., Babu, K. M., & Boyer, E. W. (2016). Suspected adulteration of commercial kratom products with 7-hydroxymitragynine. Journal of Medical Toxicology, 12(4), 341–349. doi: 10.1007/s13181-016-0588-y
   PubMed Web of Science ®Google Scholar
• Olsen, E. O., O’Donnell, J., Mattson, C. L., Schier, J. G., & Wilson, N. (2019). Notes from the field. unintentional drug overdose deaths with kratom detected – 27 States, July 2016 – December 2017. Morbidity and Mortality Weekly Report, 68(14), 326–327. doi: 10.15585/mmwr.mm6814a2
   PubMed Web of Science ®Google Scholar
• Post, S., Spiller, H. A., Chounthirath, T., & Smith, G. A. (2019). Kratom exposure reported to United States poison control centers 2011–2017. Clinical Toxicology, doi: 10.1080/15563650.2019.1569236
   Web of Science ®Google Scholar
• Prozialeck, W. C., Avery, B. A., Boyer, E. W., Grundmann, O., Henningfield, J. E., Kruegel, A. C., … Singh, D. (2019). Kratom policy: The challenge of balancing therapeutic potential with public with public safety. International Journal of Drug Policy, 70, 70–77. doi: 10.1016/j.drugpo.2019.05.003
   PubMed Web of Science ®Google Scholar
• Prozialeck, W. C., Jivan, J. K., & Andurkar, S. V. (2012). Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association, 112(12), 792–799.
   PubMedGoogle Scholar
• Rueger, S. Y., & King, A. C. (2013). Validation of the brief biphasic alcohol effects scale (B-BAES). Alcoholism: Clinical and Experimental Research, 37(3), 470–476. doi: 10.1111/j.1530-0277.2012.01941.x
   PubMed Web of Science ®Google Scholar
• Rueger, S. Y., McNamara, P. J., & King, A. C. (2009). Expanding the Utility of the biphasic alcohol effects scale (BAES) and initial psychometric support for their brief-BAES (B-BAES). Alcoholism: Clinical and Experimental Research, 33(5), 916–924. doi: 10.1111/j.1530-0277.2009.00914.x
   PubMed Web of Science ®Google Scholar
• Saingam, D., Assanangkornchai, S., Geater, A. F., & Balthip, Q. (2013). Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. International Journal of Drug Policy, 24(4), 351–358. doi: 10.1016/j.drugpo.2012.09.004
   PubMed Web of Science ®Google Scholar
• Singh, D., Muller, C. P., & Vicknasingam, B. (2014). Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence, 139, 132–137. doi: 10.1016/j.drugalcdep.2014.03.017
   PubMed Web of Science ®Google Scholar
• Singh, D., Narayanan, S., & Vicknasingam, B. (2016). Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin, 126, 41–46. doi: 10.1016/j.brainresbull.2016.05.004
   PubMed Web of Science ®Google Scholar
• Smith, K. E., & Lawson, T. (2017). Prevalence and motivations of kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence, 180, 340–348. doi: 10.1016/j.drugalcdep.2017.08.034
   PubMed Web of Science ®Google Scholar
• Suwanlert, S. (1975). A study of kratom eaters in Thailand. Bullentin on Narcotics, 27(3), 21–27.
   PubMedGoogle Scholar
• Takayama, H. (2004). Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chemical & Pharmaceutical Bulletin, 52(8), 916–928. doi: 10.1248/cpb.52.916
   PubMed Web of Science ®Google Scholar
• Tanguay, P. (2011). Kratom in Thailand: Decriminalisation and community control? Series on legislative reform of drug policies, vol. 13, International Drug Policy Consortium (IDPC).
   Google Scholar
• Vicknasingam, B., Narayanan, S., Beng, G. T., & Mansor, S. M. (2010). The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy, 21(4), 283–288. doi: 10.1016/j.drugpo.2009.12.003
   PubMed Web of Science ®Google Scholar